Eurasanté is a development agency dedicated to tech transfer and business development in life sciences sector in Northern France region. Our experienced project managers help researchers, startups and companies with their development projects. To do so, Eurasante provides many services such as real estate, fundraising, recruitment and business development. It also promotes the Eurasante Bio-business Park, which already hosts 8 hospitals, 4 universities, 8 specialised schools and more than 170 companies. It benefits from an exceptional location at the heart of Europe.
Stand
Eurofins CDMO
fr
Eurofins CDMO provides integrated, end-to-end development and manufacturing services for Drug Substance/API and Drug Product manufacturing for biologics and small molecules. We are experts for highly potent compounds, poorly soluble drugs, lyophilisation processes, orphan drugs, paediatric forms… Our services: DS Development, Solid State R&D, Preformulation, Formulation Development, GMP Manufacturing, Clinical Packaging and Logistics, CMC Regulatory Support.
Contact us: www.eurofins.com/cdmo
Stand
faCellitate
Germany
faCellitate specializes in the development of polymer surface coatings for laboratory consumables to create a fully synthetic, biologically relevant environment for cell-based assays. The highly defined and standardized products are used in areas of biomedical research such as cancer and stem cell research, early drug discovery and toxicology to enable and significantly refine the efficiency and predictability of preclinical cell-based models.
Stand
FINDMED
fr
“Carnot institute” is label awarded to research centers of excellence which have been able to demonstrate their ability to conduct research projects with industry at highest quality standards. Members of the consortium include Institut Pasteur, Institut Curie, Institut du Cerveau, Institut de la Vision, Institut Imagine (genetic diseases), Institut Calym (lymphoma), INRAE, CEA, …
Stand
IMODE
fr
IMODE is a collaborative research project for multicomponent pharmaceutical products (co-amorphous and co-crystals) and medical devices that are loaded with bioactive molecules. Started in 2016, the IMODE project is funded by the European Interreg 2 Seas programme and co-financed by the European Regional Development Fund (ERDF).
Stand
InnoSer
Belgium
Founded in 2012, InnoSer is an innovative and dynamic contract research organization (CRO) that supports the discovery and preclinical development of drugs. InnoSer’s offerings include a unique, conditional knockout model for ADPKD (nephrology) in mice, a patient derived screening-platform for oncology: PDX/O, and a first-in-class, validated, midbrain-organoid platform to screen drugs for Parkinson’s disease. Also, InnoSer provides pathology- and in-vivo research services including colony management, cryopreservation, sanitation/rederivation.
Stand
iQualit
fr
In an era of digitalization, Big Data and Data Science, data is a major part of every company. For the Life Sciences, data management is critical.
Our duty is to go with every company improving their information system, handling, hosting, and processing their data processing with quality assurance.
Our services are focused on 3 main expertise: Data Compliance, Data to Information and Data Hosting. Each service follows Life Sciences regulations and professional recommendations.
Stand
mAbexperts group: RD-Biotech, Diaclone, QVQ & sYnAbs
fr
RD-BIOTECH: French CRO. Custom services: development and production of plasmid, monoclonal antibody, recombinant protein and antibody (Fab, scFv…). Analytical platform for QC & proteins characterization.
DIACLONE: Product portfolio: mAbs (Cytokins, CD markers…), ELISA, ELISpot, SARS-CoV-2 products. Antibody development (hybridoma & phage display) & bioassays services
QVQ: VHH custom development & products
SYNABS: Anti-species secondary antibodies & mAb development (expert for small target)
Stand
MATERIA NOVA
Belgium
Materia Nova is a technological accelerator of sustainable innovations in the field of new materials and processes. The approach of Materia Nova is based on an open and collaborative innovation.
In the framework of a collaborative Interreg program, we developed a new portable device for early and specific rapid detection of microorganisms. Using DNA or antigenic probes on a plasmonic chip, this device was first dedicated to agriculture applications and is now adapted to biomedical domain.